Kimco Realty Corp <KIM.N>: Citigroup Raises Target Price To $26 From $24
KIM•Related News
Tonix Q2 FY26 net loss narrows to $40.55 million; product revenue rises to $13.54 million
TNXP•
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results For ABCL635, Demonstrating Significant Reduction In Frequency And Severity Of Vasomotor Symptoms And A Favorable Tolerability Profile
ABCL•
Canadian cannabis producer Village Farms beats Q2 sales, EPS estimates on record yields, exports
VFF•
Tenax Therapeutics' heart drug misses main goal in study, shares plunge
TENX•
Tenax says Phase 3 LEVEL trial of TNX-103 in PH-HFpEF misses primary endpoint on 6-minute walk distance
TENX•